Over the past two decades, great advances have been made in genome editing technologies. More recently, CRISPR/Cas9 has generated much excitement in the scientific and medical worlds, yet it still remains in its infancy and must mature significantly before we see it utilized in the clinic. Technical barriers such as delivery, toxicity, and off-target effects must be addressed, as do the complicated IP issues surrounding the technology.
Click for full report: A Primer on Gene Editing
In this report, Kineticos’ experts highlight the scientific and commercial impact of this revolutionary technology. Below are a few key topics addressed throughout.
- Various gene editing methods including the new CRISPR/Cas9 system
- Gene editing competitive landscape space along with their
- Current therapies in development
- Challenges faced by the CRISPR/Cas9 system
If you have any questions or comments about the research paper, we’d love to hear from you. Contact Authors